These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7744355)

  • 1. [Vigabatrin in the treatment of pediatric epileptic syndrome].
    Lahat E
    Harefuah; 1995 Mar; 128(5):306-8. PubMed ID: 7744355
    [No Abstract]   [Full Text] [Related]  

  • 2. Vigabatrin.
    Calli J; Farrington E
    Pediatr Nurs; 1998; 24(4):357-61. PubMed ID: 9849270
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of refractory infantile epilepsy with vigabatrin in a series of 55 patients].
    López-Valdés E; Hernández-Laín A; Simón R; Porta J; Mateos F
    Rev Neurol; 1996 Oct; 24(134):1255-7. PubMed ID: 8983724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F; Sopranzi N
    Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic failure, treatment and non-treatment of childhood epilepsy].
    Garaizar C; Pérez-García J; Gil-Antón J; Prats JM
    Rev Neurol; 1998 Sep; 27(157):467-72. PubMed ID: 9774821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sabril--a new antiepileptic agent.
    S Afr Med J; 1994 Oct; 84(10):33, 38. PubMed ID: 7839243
    [No Abstract]   [Full Text] [Related]  

  • 7. Vigabatrin causes profound reduction in serum alanine transaminase activity.
    Ryan MF; Samy A; Young J
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():257-8. PubMed ID: 8791991
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vigabatrin symposium within the congress "Epilepsy Europe", 3 September 1992, Glasgow].
    Nervenarzt; 1992 Dec; 63(12 Suppl):1-12. PubMed ID: 7477593
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vigabatrin--a new antiepileptic agent].
    Nakken KO; Henriksen O; Johannessen SI
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2843-4. PubMed ID: 7998031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Some new problems in the pharmacologic treatment of epilepsy].
    Trabka W; Bacia T
    Pol Tyg Lek; 1994 Jan 24-31; 49(4-5):118-21. PubMed ID: 8029138
    [No Abstract]   [Full Text] [Related]  

  • 11. Vigabatrin for refractory partial seizures in children with tuberous sclerosis.
    Curatolo P
    Neuropediatrics; 1994 Feb; 25(1):55. PubMed ID: 8208356
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual field constriction in children treated with vigabatrin.
    Vanhatalo S; Pääkkönen L; Nousiainen I
    Neurology; 1999 May; 52(8):1713-4. PubMed ID: 10331710
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal hepatotoxicity in a child treated with vigabatrin.
    Kellermann K; Soditt V; Rambeck B; Klinge O
    Acta Neurol Scand; 1996 May; 93(5):380-1. PubMed ID: 8800351
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vigabatrin in the treatment of infantile spasms].
    Backström M; Eriksson K; Koivikko M
    Duodecim; 1995; 111(9):853-5. PubMed ID: 8681848
    [No Abstract]   [Full Text] [Related]  

  • 15. Vigabatrin.
    Shields WD; Sankar R
    Semin Pediatr Neurol; 1997 Mar; 4(1):43-50. PubMed ID: 9097366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin in newly diagnosed infantile spasms.
    Schmitt B; Wohlrab G; Boltshauser E
    Neuropediatrics; 1994 Feb; 25(1):54. PubMed ID: 8208355
    [No Abstract]   [Full Text] [Related]  

  • 17. 'A simple, effective and well-tolerated treatment regime for West Syndrome'.
    Appleton RE
    Dev Med Child Neurol; 1995 Feb; 37(2):185-6. PubMed ID: 7851675
    [No Abstract]   [Full Text] [Related]  

  • 18. [Subsequent manic disorder due to combination vigabatrin-clomipramine].
    Sastre-Garau P; Thomas P; Beaussart M; Goudemand M
    Encephale; 1994; 20(3):363. PubMed ID: 8088239
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions.
    Wilson EA; Brodie MJ
    BMJ; 1997 Jun; 314(7095):1693. PubMed ID: 9193311
    [No Abstract]   [Full Text] [Related]  

  • 20. Aminoaciduria resulting from vigabatrin administration in children with epilepsy.
    Lahat E; Ben-Zeev B; Zlotnik J; Sela BA
    Pediatr Neurol; 1999 Jul; 21(1):460-3. PubMed ID: 10428431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.